Pall Enters Laboratory Water Market With New Cascada Lab Water System

Food and Healthcare Press Releases Tuesday March 1, 2005 16:46
EAST HILLS, N.Y.--(BUSINESS WIRE)--Feb. 28, 2005--

Purified water is an essential and growing requirement of research and diagnostic laboratories. Water quality can wreak havoc on sensitive equipment andtest results. To meet demanding life science and analytical testingrequirements, Pall Corporation (NYSE: PLL), the global leader infiltration, separations and purification, announced that it isbringing its water purification expertise to the laboratory marketwith the introduction of the Pall Cascada(TM) Lab Water Systems. TheCascada point-of-use system provides optimum water quality to supportdiverse laboratory needs from the most critical, sensitiveapplications through general-purpose use.

"As the lab market becomes increasingly complex and demanding,customers need trustworthy providers that are deeply entrenched inwater purification," says Ken L. Harris, President Pall Life SciencesNew Technology. "Pall's entry into this marketplace combines more thana half century experience in the development of the most advancedwater purification technologies used by a host of industries worldwidewith our in-depth, extensive knowledge and understanding of thediverse application needs of the laboratory markets we serve."

The Cascada System enables laboratories to achieve the highestpurity water through a series of separation and purification steps ina single box on demand. Four polishing systems, with customizedconfigurations to meet a wide range of sensitive application requiresfor high quality ultrapure water, are available. A pretreatment systemis also available to protect and extend the life of the polishers,which is particularly important in cases where there is poor feedwaterquality.

Expanding Market with Unmet Needs

"The lab water market continues to expand and rapid technologicalgrowth in regions of the world, such as Asia and Latin America, stillhave many unmet needs. We are confident we will be one of the leadingproviders of point-of-use laboratory water systems in the nearfuture," says Mr. Harris.

The global laboratory water systems and consumables market isestimated at $250 million dollars, growing at a rate of about 8percent annually.

"Pall selected the best available technology for our new system tomonitor and protect the quality of the output water at the least costof ownership for academic, clinical, biopharmaceutical andpharmaceutical research laboratories," Mr. Harris adds. "The newCascada system is merely the tip of the iceberg for Pall in thismarketplace."

The Company plans to extend its dominant position in waterpurification by utilizing its proprietary technologies to continue torefine systems and lead in the growing, changing and ever moredemanding laboratory water market.

About Pall Corporation

Pall Corporation is the global leader in the rapidly growing fieldof filtration, separations and purification. Pall's business isorganized around two broad markets: Life Sciences and Industrial. TheCompany provides leading-edge products to meet the demanding needs ofcustomers in biotechnology, pharmaceutical, transfusion medicine,semiconductors, water purification, aerospace and broad industrialmarkets. Total revenues are $1.8 billion. The Company headquarters arein East Hills, New York with extensive operations throughout theworld. Visit Pall at www.pall.com.

Forward Looking Statement

This release contains "forward-looking statements" as defined inthe Private Securities Litigation Reform Act of 1995. These statementsare based on current Company expectations and are subject to risks anduncertainties which could cause actual results to differ materially.Such risks and uncertainties include, but are not limited to:fluctuations in foreign currency exchange rates; regulatory approvaland market acceptance of new technologies; changes in product mix andproduct pricing and in interest rates and cost of raw materials; theCompany's success in enforcing its patents and protecting itsproprietary products and manufacturing techniques and its ability toachieve the savings anticipated from its cost reduction initiatives;global and regional economic conditions and legislative, regulatoryand political developments; and domestic and international competitionin the Company's global markets. Additional information regardingthese and other factors is available on the Web at www.pall.com and isincluded in the Company's reports filed with the U.S. Securities andExchange Commission. Copies of such reports can be obtained, withoutcharge, at www.sec.gov.

Management uses certain non-GAAP measurements to assess Pall'scurrent and future financial performance. The non-GAAP measurements donot replace the presentation of Pall's GAAP financial results. Thesemeasurements provide supplemental information to assist management inanalyzing Pall's financial position and results of operations. Pallhas chosen to provide this information to facilitate meaningfulcomparisons of past, present and future operating results and as ameans to emphasize the results of ongoing operations.

Editors Note:
Product photos and additional information can be found onwww.pall.com/corporate_35507.asp
CONTACT: Pall Corporation
Patricia Iannucci, 516- 801-9100
E-mail: piannucci@pall.com
Source: Business Wire Press Release

Latest Press Release

Experts Call for Improved Identification of #High Burden# Rosacea Patients in Everyday Practice

- Additional analysis of global survey data reveals quality of life is impacted by several factors extending beyond severity of rosacea alone Additional analysis of a global survey conducted and presented earlier this year, as an expert-authored report...

BookDoc collaborates with Chow Tai Fook: Get more rewards by staying active together with Chow Tai Fook

Chow Tai Fook is collaborating with BookDoc, the largest integrated healthcare app in Southeast Asia by healthcare network in giving more rewards to BookDoc users for maintaining an active healthy lifestyle. Users can now enjoy discounts and redeem...

MEDICAL WINGS THAILAND BASED AIR AMBULANCE OPERATOR ACHIEVES FULL ACCREDITATION FROM CAMTS AND CAMTS EU AND BECOMES THE FIRST OPERATOR IN ASIA TO ACHIEVE THE #DUAL ACCREDITATION

Medical Wings, the air ambulance division of Siam Land Flying Company, a subsidiary company of Charoen Pokphand Group (C.P. Group), is proud to achieve full re-accreditation of its existing CAMTS approval as well as attaining the new CAMTS EU...

Photo Release: CGH Group Hospital held the event Happy Life with Healthy Bone and Joints Seminar in Yangon, Myanmar.

CGH Group Hospital recently held a live health talk in Yangon, Myanmar to highlight the important health issues on bone and joints for all Myanmar people. A team of medical experts led by Dr. Wanchai Sirisereewan (4th from left), CGH's Orthopedic Surgeon...

BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) Significantly Improved Progression-Free Survival in Previously Untreated Patients With Advanced Renal Cell Carcinoma in Phase III Study

- First positive Phase III immunotherapy trial in combination with a tyrosine kinase inhibitor (TKI) in any tumor type - Results significant in both PDL1+ and all-comer populations - Alliance plans to pursue a regulatory submission in the US and...

Related Topics